{"count": 39, "results": [{"_id": "33152659", "pmid": 33152659, "title": "Postmortem fatal and non-fatal concentrations of amlodipine.", "journal": "Forensic Sci Int", "authors": ["Alvarez JC", "Mayer-Duverneuil C", "Cappy J", "Lorin de la Grandamison G", "Knapp-Gisclon A"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.forsciint.2020.110555", "meta_date_publication": "2020 Nov", "meta_volume": "316", "meta_issue": "", "meta_pages": "110555", "score": 50267.105, "text_hl": "...@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ is a @CHEMICAL_1_4_dihydropyridine @CHEMICAL_MESH:C038806 @@@dihydropyridine@@@ calcium channel blocker widely used in the treatment of high blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ and @DISEASE_Coronary_Disease @DISEASE_MESH:D003327 @@@coronary heart disease@@@. ", "citations": {"NLM": "Alvarez JC, Mayer-Duverneuil C, Cappy J, Lorin de la Grandamison G, Knapp-Gisclon A. Postmortem fatal and non-fatal concentrations of amlodipine. Forensic Sci Int. 2020 Nov;316():110555. PMID: 33152659", "BibTeX": "@article{33152659, title={Postmortem fatal and non-fatal concentrations of amlodipine.}, author={Alvarez JC and Mayer-Duverneuil C and Cappy J and Lorin de la Grandamison G and Knapp-Gisclon A}, journal={Forensic Sci Int}, volume={316}, pages={110555}}"}}, {"_id": "37341147", "pmid": 37341147, "title": "Blood pressure control following angiotensin antagonists substitution: insights from a triple-blind, randomized, clinical trial.", "journal": "J Clin Pharmacol", "authors": ["Sharifan A", "Bahreini M", "Ashraf H", "Najmeddin F"], "date": "2023-06-21T00:00:00Z", "doi": "10.1002/jcph.2294", "meta_date_publication": "2023 Jun 21", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50266.184, "text_hl": "No significant deviations were seen in @SPECIES_9606 @@@patients@@@' systolic blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ by substituting an ACEI/ARB agent with the CCB @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ with or without the alpha/beta-blocker @CHEMICAL_Carvedilol @CHEMICAL_MESH:D000077261 @@@carvedilol@@@. ", "citations": {"NLM": "Sharifan A, Bahreini M, Ashraf H, Najmeddin F. Blood pressure control following angiotensin antagonists substitution: insights from a triple-blind, randomized, clinical trial. J Clin Pharmacol. 2023 Jun 21;():. PMID: 37341147", "BibTeX": "@article{37341147, title={Blood pressure control following angiotensin antagonists substitution: insights from a triple-blind, randomized, clinical trial.}, author={Sharifan A and Bahreini M and Ashraf H and Najmeddin F}, journal={J Clin Pharmacol}}"}}, {"_id": "37553138", "pmid": 37553138, "title": "Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure.", "journal": "Heart", "authors": ["Atkins ER", "Chye A", "Lung T", "Nolde JM", "Billot L", "Burke M", "Chalmers J", "Figtree GA", "Hay P", "Hillis GS", "Jansen S", "Marschner S", "Neal B", "Nelson MR", "Reid CM", "Usherwood T", "Schlaich M", "Chow CK", "Rodgers A"], "date": "2023-07-26T00:00:00Z", "doi": "10.1136/heartjnl-2022-322300", "meta_date_publication": "2023 Jul 26", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50255.4, "text_hl": "Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@.", "citations": {"NLM": "Atkins ER, Chye A, Lung T, Nolde JM, Billot L, Burke M, Chalmers J, Figtree GA, Hay P, Hillis GS, Jansen S, Marschner S, Neal B, Nelson MR, Reid CM, Usherwood T, Schlaich M, Chow CK, Rodgers A. Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure. Heart. 2023 Jul 26;():. PMID: 37553138", "BibTeX": "@article{37553138, title={Cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure.}, author={Atkins ER and Chye A and Lung T and Nolde JM and Billot L and Burke M and Chalmers J and Figtree GA and Hay P and Hillis GS and Jansen S and Marschner S and Neal B and Nelson MR and Reid CM and Usherwood T and Schlaich M and Chow CK and Rodgers A}, journal={Heart}}"}}, {"_id": "38017457", "pmid": 38017457, "pmcid": "PMC10685633", "title": "The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}", "journal": "Trials", "authors": ["Xu M", "Zhang X", "Ye R", "Liu X", "Sun L", "Jia S", "Zhang Z", "Li X", "Wang Z", "Liao H", "Shi R", "Liu K", "Wang S", "Meng Q", "Chen X"], "date": "2023-11-28T00:00:00Z", "doi": "10.1186/s13063-023-07726-x", "meta_date_publication": "2023 Nov 28", "meta_volume": "24", "meta_issue": "1", "meta_pages": "770", "score": 50253.547, "text_hl": "The secondary objectives are the reduction in ambulatory blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ at weeks 4 and 12 and the blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ control rate at weeks 4, 8, and 12.", "citations": {"NLM": "Xu M, Zhang X, Ye R, Liu X, Sun L, Jia S, Zhang Z, Li X, Wang Z, Liao H, Shi R, Liu K, Wang S, Meng Q, Chen X. The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1} Trials. 2023 Nov 28;24(1):770. PMID: 38017457", "BibTeX": "@article{38017457, title={The effects of Olmesartan/amlodipine administered in the Morning or At Night on nocturnal blood pressure reduction in Chinese patients with mild-moderate essential hypertension (OMAN Trial): study protocol for a prospective, multicenter, randomized, open-label clinical trial {1}}, author={Xu M and Zhang X and Ye R and Liu X and Sun L and Jia S and Zhang Z and Li X and Wang Z and Liao H and Shi R and Liu K and Wang S and Meng Q and Chen X}, journal={Trials}, volume={24}, number={1}, pages={770}}"}}, {"_id": "35772708", "pmid": 35772708, "title": "Multiple Cerebral Aneurysms Treated by Microsurgical and Endovascular Technique.", "journal": "World Neurosurg", "authors": ["Konan ML", "Tokpa A", "Okamon M", "Wilfried M", "N'gassa A", "Brou J", "Djondé G", "Oka DN"], "date": "2022-09-01T00:00:00Z", "doi": "10.1016/j.wneu.2022.06.103", "meta_date_publication": "2022 Sep", "meta_volume": "165", "meta_issue": "", "meta_pages": "132", "score": 50235.855, "text_hl": "Her medical history was significant: an episode of @DISEASE_Eclampsia @DISEASE_MESH:D004461 @@@eclampsia@@@ 20 years ago and high blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ managed with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@. ", "citations": {"NLM": "Konan ML, Tokpa A, Okamon M, Wilfried M, N'gassa A, Brou J, Djondé G, Oka DN. Multiple Cerebral Aneurysms Treated by Microsurgical and Endovascular Technique. World Neurosurg. 2022 Sep;165():132. PMID: 35772708", "BibTeX": "@article{35772708, title={Multiple Cerebral Aneurysms Treated by Microsurgical and Endovascular Technique.}, author={Konan ML and Tokpa A and Okamon M and Wilfried M and N'gassa A and Brou J and Djondé G and Oka DN}, journal={World Neurosurg}, volume={165}, pages={132}}"}}, {"_id": "23837008", "pmid": 23837008, "pmcid": "PMC3699292", "title": "Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination", "journal": "Integr Blood Press Control", "authors": ["Hovater MB", "Jaimes EA"], "date": "2013-06-14T00:00:00Z", "doi": "10.2147/IBPC.S32649", "meta_date_publication": "2013", "meta_volume": "6", "meta_issue": "", "meta_pages": "59-67", "score": 50079.53, "text_hl": "...@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@", "citations": {"NLM": "Hovater MB, Jaimes EA. Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination Integr Blood Press Control. 2013;6():59-67. PMID: 23837008", "BibTeX": "@article{23837008, title={Optimizing combination therapy in the management of hypertension: the role of the aliskiren, amlodipine, and hydrochlorothiazide fixed combination}, author={Hovater MB and Jaimes EA}, journal={Integr Blood Press Control}, volume={6}, pages={59-67}}"}}, {"_id": "29276920", "pmid": 29276920, "title": "[Blood Pressure Variability. Visit-to-Visit Blood Pressure Variability].", "journal": "Kardiologiia", "authors": ["Ostroumova OD", "Borisova EV", "Pavleeva EE"], "date": "2017-11-01T00:00:00Z", "doi": "10.18087/cardio.2017.11.10056", "meta_date_publication": "2017 Nov", "meta_volume": "57", "meta_issue": "11", "meta_pages": "68-75", "score": 50079.26, "text_hl": "[Blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@Pressure@@@ Variability. ", "citations": {"NLM": "Ostroumova OD, Borisova EV, Pavleeva EE. [Blood Pressure Variability. Visit-to-Visit Blood Pressure Variability]. Kardiologiia. 2017 Nov;57(11):68-75. PMID: 29276920", "BibTeX": "@article{29276920, title={[Blood Pressure Variability. Visit-to-Visit Blood Pressure Variability].}, author={Ostroumova OD and Borisova EV and Pavleeva EE}, journal={Kardiologiia}, volume={57}, number={11}, pages={68-75}}"}}, {"_id": "16686086", "pmid": 16686086, "title": "[The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].", "journal": "Ned Tijdschr Geneeskd", "authors": ["van den Meiracker AH", "van Montfrans GA"], "date": "2006-04-22T00:00:00Z", "meta_date_publication": "2006 Apr 22", "meta_volume": "150", "meta_issue": "16", "meta_pages": "886-8", "score": 50076.203, "text_hl": "[The most recent study into blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ lowering by @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@: the beginning of the end for the beta-blockers].", "citations": {"NLM": "van den Meiracker AH, van Montfrans GA. [The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers]. Ned Tijdschr Geneeskd. 2006 Apr 22;150(16):886-8. PMID: 16686086", "BibTeX": "@article{16686086, title={[The most recent study into blood pressure lowering by amlodipine: the beginning of the end for the beta-blockers].}, author={van den Meiracker AH and van Montfrans GA}, journal={Ned Tijdschr Geneeskd}, volume={150}, number={16}, pages={886-8}}"}}, {"_id": "30883050", "pmid": 30883050, "title": "Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.", "journal": "N Engl J Med", "authors": ["Ojji DB", "Mayosi B", "Francis V", "Badri M", "Cornelius V", "Smythe W", "Kramer N", "Barasa F", "Damasceno A", "Dzudie A", "Jones E", "Mondo C", "Ogah O", "Ogola E", "Sani MU", "Shedul GL", "Shedul G", "Rayner B", "Okpechi IG", "Sliwa K", "Poulter N", "CREOLE Study Investigators"], "date": "2019-06-20T00:00:00Z", "doi": "10.1056/NEJMoa1901113", "meta_date_publication": "2019 Jun 20", "meta_volume": "380", "meta_issue": "25", "meta_pages": "2429-2439", "score": 50074.734, "text_hl": "Among the 621 @SPECIES_9606 @@@patients@@@ who underwent 24-hour blood-@<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ monitoring at baseline and at 6 months, those receiving @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ plus @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ and those receiving @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ plus @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ had a lower 24-hour ambulatory systolic blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ than those receiving @CHEMICAL_Perindopril @CHEMICAL_MESH:D020913 @@@perindopril@@@ plus @CHEMICAL_Hydrochlorothiazide @CHEMICAL_MESH:D006852 @@@hydrochlorothiazide@@@ (between-group difference in the change from baseline, -3.14 mm Hg; 95% confidence interval [CI], -5.90 to -0.38; P = 0.03; and -3.00 mm Hg; 95% CI, -5.8 to -0.20; P = 0.04, respectively). ", "citations": {"NLM": "Ojji DB, Mayosi B, Francis V, Badri M, Cornelius V, Smythe W, Kramer N, Barasa F, Damasceno A, Dzudie A, Jones E, Mondo C, Ogah O, Ogola E, Sani MU, Shedul GL, Shedul G, Rayner B, Okpechi IG, Sliwa K, Poulter N, CREOLE Study Investigators. Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans. N Engl J Med. 2019 Jun 20;380(25):2429-2439. PMID: 30883050", "BibTeX": "@article{30883050, title={Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.}, author={Ojji DB and Mayosi B and Francis V and Badri M and Cornelius V and Smythe W and Kramer N and Barasa F and Damasceno A and Dzudie A and Jones E and Mondo C and Ogah O and Ogola E and Sani MU and Shedul GL and Shedul G and Rayner B and Okpechi IG and Sliwa K and Poulter N and CREOLE Study Investigators}, journal={N Engl J Med}, volume={380}, number={25}, pages={2429-2439}}"}}, {"_id": "9757170", "pmid": 9757170, "title": "The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.", "journal": "CMAJ", "authors": ["Wilson TW", "Lacourcière Y", "Barnes CC"], "date": "1998-09-08T00:00:00Z", "meta_date_publication": "1998 Sep 8", "meta_volume": "159", "meta_issue": "5", "meta_pages": "469-76", "score": 50072.26, "text_hl": "The antihypertensive efficacy of @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ and @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ assessed with office and ambulatory blood @<m>DISEASE_Pressure_Ulcer</m> @DISEASE_MESH:D003668 @@@pressure@@@ monitoring. ", "citations": {"NLM": "Wilson TW, Lacourcière Y, Barnes CC. The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group. CMAJ. 1998 Sep 8;159(5):469-76. PMID: 9757170", "BibTeX": "@article{9757170, title={The antihypertensive efficacy of losartan and amlodipine assessed with office and ambulatory blood pressure monitoring. Canadian Cozaar Hyzaar Amlodipine Trial Study Group.}, author={Wilson TW and Lacourcière Y and Barnes CC}, journal={CMAJ}, volume={159}, number={5}, pages={469-76}}"}}]}